Image

2019 Cannabis Business Award's

Publication of the Year

WEDNESDAY, MAY 10, 2023

 REGISTER FOR TONIGHT'S 

MEETING 

MAY 10, 2023 

SPECIAL LEGISLATIVE UPDATE 

 

 THE

"FLORIDA MEDICAL CANNABIS

PHYSICIAN GROUP"

(FMCPG)

FOR ALL

"MEDICAL MARIJUANA DOCTORS"

AND "MMTC DIRECTORS ONLY "

 

SIGN UP TODAY

 

TOPICS TO BE DISCUSSED 

 

FOLLOW UP ON RECENT DEVELOPMENTS ON 2023 LEGISLATIVE ISSUES

FROM OUR APRIL 26TH MEETING 

WHAT CAN HURT YOUR PRACTICE

 

UPDATE FROM TALLAHASSEE ON TELEHEALTH BILL FOR CANNABIS PATIENTS

PASSED BY THE HOUSE AND SENATE, NOW WAITNG FOR THE GOVERNOR

 

UPDATE FROM TALLAHASSEE ON THE HEMP BILL 

 

PROTECTING YOUR MEDICAL CANNABIS PRACTICE 

 

QUESTIONS FROM PHYSICIANS 

 

HOW TO BEST ANSWER YOUR PATIENT QUESTIONS 

CLICK HERE TO REGISTER FOR THE

MAY 10  MEETING

 

JOIN CANNABIS NEWS FLORIDA AND

FLORIDA MEDICAL CANNABIS PHYSICIANS GROUP

AT FMCCE ON JUNE 2 - 4 IN ORLANDO

ASK ABOUT FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP DISCOUNT 

 

Email me at: charles@cannabisnewsflorida.com

phone: 954-605-4785

 
 

NEWS FROM THE PAST WEEK

RELATING TO THE BUSINESS OF CANNABIS IN FLORIDA

 

Click on Company Logo to be Transferred to Web Site

 

 

CLICK HERE FOR MORE INFORMATION ABOUT THE SUNBURN CANNABIS PROMOTIONS

 

CLICK HERE FOR MORE INFORMATION ABOUT

INSA PROMOTIONS 

 
 
 
 
 

NEW NAME

HOUSE OF PLATINUM CANNABIS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

NATIONAL AND INTERNATIONAL NEWS

SPRINGBIG REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS

May 04, 2023 — SpringBig Holdings, Inc. (“springbig” or the “Company”) (NASDAQ: SBIG), a leading provider of SaaS-based marketing solutions, consumer mobile app experiences, and omnichannel loyalty programs to the cannabis industry, today announced its financial results for the first quarter ended March 31, 2023.

“I am pleased with our execution to begin the year and with progress we are making across a number of new initiatives,” said Jeffrey Harris, CEO and Chairman of springbig. “We are managing our business efficiently with a keen eye on measured growth focused on profitability while recognizing the current macro and industry-specific realities. I am as confident as ever that our strategy is sound, with feedback from customers and partners reaffirming that we are making the right investments to capture the long-term opportunity in front of us.”

READ MORE

 

OPTIMI HEALTH ANNOUNCES CAD$1.2 MILLION GMP PSILOCYBIN SUPPLY AGREEMENT FOR CLINICAL RESEARCH AND DEVELOPMENT

The Company’s entire cultivation facility has been mobilized to service supply agreements

VANCOUVER, British Columbia, May 04, 2023 — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), today announced that it has entered into a CAD$1.2 million definitive supply agreement with a private entity focused on developing mushroom-based therapeutic drugs through pre-clinical research and clinical trials.

Under Canada’s Controlled Drugs and Substances regulations, Optimi functions as an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research purposes, psychedelic substances such as 3,4-Methylenedioxymethamphetamine (“MDMA”), natural GMP-grade psilocybin, and high-quality functional mushrooms.

To fulfill its obligations, Optimi is cultivating dried GMP psilocybin-containing biomass and extract into a refined substance, which will be distributed to the Client’s international research sites.

This announcement affirms Optimi’s commitment to GMP production capabilities and its ability to supply large scale research and development programs.


READ MORE

 

AVICANNA AND NORTHERN GREEN CANADA EXECUTE MASTER SERVICE AGREEMENT TO OPERATIONALIZE MYMEDI.CA

MyMedi.ca to provide Medical Cannabis by Shoppers patients a complete medical cannabis care platform including curated products and services.

NGC will facilitate inventory management and fulfillment through its EU GMP-certified and Health Canada licensed infrastructure starting Q2, 2023.

TORONTO, May 04, 2023 — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that it has entered into a Master Service Agreement (“MSA”) with Northern Green Canada (“NGC”) a federally-licensed EU GMP-certified cannabis producer to operationalize MyMedi.ca medical cannabis care platform’s logistics and fulfilment infrastructure.

Through the MSA, NGC will provide the MyMedi.ca medical cannabis care platform with regulatory support and access to appropriate Health Canada licenses in addition to services related to inventory management and quality assurance. NGC will also contribute to the MyMedi.ca medical cannabis care platform’s formulary of products with its own EU GMP-certified proprietary genetics and finished products.

READ MORE

 

VILLAGE FARMS INTERNATIONAL ANNOUNCES LAUNCH OF ITS CANNABIS PRODUCTS IN GERMANY

Launch of Pure Sunfarms-Grown Products Follows Start of Sales to Israel in January

VANCOUVER, British Columbia, May 04, 2023  — Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced the launch in Germany of cannabis products grown by its Canadian Cannabis business (wholly owned subsidiary, Pure Sunfarms). The German launch is in partnership with IUVO Therapeutics GmbH (“IUVO”), an importer, marketer and distributor of medical cannabis for the German market. IUVO expects Pure Sunfarms’ Pink Kush to be available to German patients in the coming days.

“Commencing cannabis product sales in Germany is another meaningful step forward in our international cannabis strategy,” said Michael DeGiglio, Chief Executive Office, Village Farms. “Robust consumer demand for our differentiated products, led by the same Pink Kush dried flower that will be available to German consumers, drove a ten-fold increase in Village Farms’ cannabis exports to Australia during 2022. Together with Australia and Israel, Germany adds a third international market where we have demonstrated our ability to respond to rigorous testing standards and deliver an exceptional product to medical consumers. Pursuing more profitable export opportunities is an important part of our growth strategy, while we continue to delight Canadian consumers with our consistent, high quality, British Columbia-grown flower.”

READ MORE

 

CANNALOGUE LAUNCHES CLEAN TECHNOLOGY E-CURRENCY CANNALOGUE DOLLARS

Transfer to Cannalogue and Receive $150 Cannalogue Dollars

TORONTO, May 04, 2023 — Healthcare technology firm, Cannalogue launches new clean technology e-currency called Cannalogue Dollars in Canada. Transfer to Cannalogue.ca and receive $150 Cannalogue Dollars towards the next six (6) medical cannabis purchases. The new clean technology solution by Cannalogue highlights significant advancements in the medical field from Canada. “We are incredibly excited to announce the Cannalogue Dollars transfer program. The Cannalogue Dollars e-currency adds tremendous value to our healthcare technology ecosystem” says President & CEO of Cannalogue, Dr. Mohan Cooray.

READ MORE

 

CAN B CORP. REPORTS GROWTH OF 45% TO COMPANY ALL-TIME HIGH $6.7 MILLION ANNUAL REVENUE

Led by Significant Increase in Duramed

Adjusted EBITDA Loss Decreased by 25% to $2.1 Million

HICKSVILLE, NY – April 19, 2023 – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing and selling hemp derived cannabinoid products, today announced the Company’s financial results for the twelve months ended December 31, 2022.

Key Financial Highlights for 2022
• Revenue increased 45% to $6.7 million.
• Gross profit decreased 13% to $2.6 million.
• Gross margin decreased to 39.1%, due to a higher revenue percentage     mix from Duramed.
• Adjusted EBITDA loss decreased by 25% to $2.1 million.
• Accounts receivable at $6.6 million
• Inventory at $2.0 million
• Total assets at $15.6 million
• Total stockholders’ equity at $2.7 million

Key Business Highlights for 2022
• Solidified and integrated vertical processing capabilities
• Signed Manufacturing and Distribution Agreement for Superfood Products   with Forever Brands and Brooke Burke via BB Body, Inc.
• Consolidated hemp processing operations from Florida and Tennessee to   Colorado.
• Expanded CBD isolate production into new isomers in expanded   Colorado  lab.
• Expanded durable medical devices to include back support devices for   Duramed division.

READ MORE

 

TREEZ RETAILERS SEE RECORD GROWTH AS PART OF THEIR 2023 4/20 RETAIL REPORT

SAN FRANCISCO, May 03, 2023 — Treez, the leading enterprise commerce technology platform that streamlines retail operations within the cannabis industry, releases its annual 4/20 retail report examining hundreds of dispensary sales data across the highest volume shops in the largest cannabis markets in 13 states to determine the biggest wins, losses and product trends during the cannabis industry’s biggest holiday. Unlike other point-of-sale (POS) providers, Treez’s POS system delivered on 4/20 with zero outages reported, resulting in 99.99% of services in operation.

As expected Treez retail customers had an amazing 420 with a year-over-year aggregated sales increase of 32% in total revenue as well as, a 44% increase in customer count compared to 2022. Some of the highlights include a 252% increase in total revenue in the state of Missouri, a 195% increase in total revenue in Colorado, a 37% increase in total revenue in Michigan, and a 36% increase in total revenue in California. The data indicates that the cannabis market is continuing to grow and evolve, with new states legalizing adult-use and medical cannabis every year and the popularity of certain product types and payment methods shifting over time. In an effort to support retailers across the nation, Treez provides the following data.


READ MORE

 

MARIMED REPORTS FIRST QUARTER 2023 EARNINGS

NORWOOD, Mass., May 08, 2023 — MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the first quarter ended March 31, 2023.

“I am pleased to report another solid quarter,” said Jon Levine, Chief Executive Officer. “We reported our 13th consecutive quarter of positive adjusted EBITDA, and we expect to generate our fourth consecutive year of positive operating cash flow. MariMed is one of the only companies in the cannabis industry to report positive cash flows and positive EBITDA over this extended period of time.”

FIRST QUARTER 2023 OPERATIONAL HIGHLIGHTS

During the first quarter, the Company announced the following developments in the implementation of its strategic growth plan:

January 24: Closed a $35 million senior secured credit facility with a $30 million draw down at close and the ability to draw up to an additional $5 million through June 2023. The facility has a three-year maturity and bears interest at a rate of prime plus 5.75%. Funds are expected to be used for capital expenditures, other corporate expenses, and acquisitions.

March 13: Closed the acquisition of the operating assets of Ermont, Inc., pursuant to which the Company obtained a vertical cannabis operation in Quincy, MA and rebranded the retail operation to Panacea Wellness Dispensary. MariMed intends to expand the dispensary to accommodate adult use sales, which the company has applied for with the State Cannabis Commission.

READ MORE

 

BELOW ARE THE  LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND

DISPENSARIES IN THE STATE OF FLORIDA

Link to current Qualified Medical Marijuana Physicians in Florida>

Listing of MMTC dispensing facilities>

 
 

CLICK HERE TO REVIEW PREVIOUSLY PUBLISHED E-NEWSLETTERS

 

 QUALIFIED PATIENTS

OVER 814,000

AND

564

DISPENSING LOCATIONS

Image

LATEST OMMU REPORTS FROM OFFICE OF MEDICAL  MARIJUANA USE IN THE STATE OF FLORIDA

Highlights from 
MAY 5, 2023

Report 

BY THE NUMBERS

Qualified Patients: (Active ID Card):

MAY   05  2023-              814,965

APR   28  2023-              812,944

APR   21  2023-              810,675

APR   14  2023-              807,438

APR    07 2023-              805,491

 

Patients Last Week: 2,021

Qualified Ordering Physicians: 2,427

New Doctors Last Week: - 31

 

Reporting Period:  APR 28-  MAY 4 2023

Amount of Medical Marijuana Dispensed -  (mgs THC)  295,283,228

Amount of Low-THC Cannabis Dispensed -  (mgs CBD) 2,915,297

Amount of Marijuana in a From for Smoking (oz) 101,211.867

Approved Dispensing Locations: 564

 

ADD LAST WEEK +0

CLICK HERE FOR CURRENT OMMU REPORT
Alternate text
 

UPCOMING MEETING AND CONFERENCES

 
 
https://fmcce.com/

THE

FLORIDA MEDICAL CANNABIS PHYSICIANS GROUP

 

ANNUAL IN-PERSON MEETING WILL BE HELD

AT THE

 

FLORIDA MEDICAL CANNABIS CONFERENCE & EXHIBITION 

 

SEE INFORMATION BELOW FOR REGISTRATION 

 
 
 
 

ADVERTISEMENT OPPORTUNITIES

 

If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.

 

Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:

· MMTC PROMOS LISTED IN EACH E-NEWSLETTER 
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters


For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com

 

Click Here to Unsubscribe

 

CANNABIS NEWS FLORIDA

{YOURCOMPANY.ADDRESS}

{COPYRIGHT.YEAR}